Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism

Transplant Immunology

Volumn 21, Issue 3, 2009, Pages 169-178

  Lobashevsky, A L ^a   Manwaring, J E ^a   Travis, M M ^a   Nord, B L ^a   Higgins, N G ^a   Serov, Y A ^a   Arnoff, T S ^a   Hommel Berrey, G A ^a   Goggins, W C ^b   Taber, T E ^c   Carter Sr , C B ^c   Smith, D S ^b   Wozniak, T C ^c   O'Donnell, J A ^c   Turrentine, M W ^b  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b INDIANA UNIVERSITY   (United States)

^c METHODIST HOSPITAL   (United States)

Author keywords

Cytokines; Desensitization; Genomic polymorphism; High PRA

Indexed keywords

ANTIBODY; CYTOKINE; DNA; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DESENSITIZATION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ANALYSIS; GENOTYPE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; MALE; ORGAN TRANSPLANTATION; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ANTIBODIES; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 67349280284     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.03.002     Document Type: Article

References (55)

1. Akalin E., and Bromberg J. Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients. Hum Immunol 66 4 (2005) 359-363 2005
2. Lee M., Moore D., and Markmann J. Regulatory CD4+CD25+T cells in prevention of allograft rejection. Front Biosci 8 9 (2003) 968-981
3. Appel J., Hartwig M., Davis R., and Reinsmoen N. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum Immunol 66 4 (2005) 378-386
4. Gloor J., DeGoey S., Ploeger N., Gebel H., Bray R., Moore S., et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 78 2 (2004) 221-227
5. Glotz D., Antoine C., and Julia P. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies. Transpl Int 17 1 (2004) 1-8
6. Zachary A., Montgomery R., Ratner L., Samaniego-Picota M., Haas M., Kopchaliiska D., et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76 10 (2003) 1519-1525
7. Zachary A., Montgomery R., and Leffell M. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 66 4 (2005) 364-370
8. Jordan S., Cunningham-Rundles C., and McEwan R. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 3 6 (2003) 653-664
9. Furth S., Neu A., Hart J., Zachary A., Colombani P., and Fivush B. Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report. Pediatr Transplant 3 2 (1999) 146-149
10. Jordan S., Tyan D., Stablein D., McIntosh M., Rose S., Vo A., et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15 12 (2004) 3256-3262
11. Jordan S., Vo A., Peng A., Toyoda M., and Tyan D. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 6 3 (2006) 459-466
12. Sonnenday C., Ratner L., Zachary A., Burdick J., Samaniego M., Kraus E., et al. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc 34 5 (2002) 1614-1616 Ref ID: 47
13. Thielke J., DeChristopher P.J., and Sankary H. Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis. Transplant Proc 37 2 (2005) 643-644
14. Ferrari-Lacraz S., Aubert V., and Buhler L. Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation. Swiss Med Wkly 136 43-44 (2006) 696-702
15. Cai J., and Terasaki P. Humoral theory of transplantation: mechanism, prevention, and treatment. Hum Immunol 66 4 (2005) 334-342
16. Vo A., Lukovsky M., Toyoda M., and Wang J. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359 3 (2008) 242-251
17. Hill N., and Sarvetnick N. Cytokines: promoters and dampeners of autoimmunity. Curr Opin Immunol 14 6 (2002) 791-797
18. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A., and Strom T. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 6 5 (1994) 757-764
19. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 9 1 (1997) 17-23
20. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 15 3 (1995) 121-129
21. Mazzinghi B., Netti G., Lazzeri E., and Romagnani P. Chemokines: possible therapeutic targets and useful clinical parameters in renal transplantation. G Ital Nefrol 24 3 (2007) 212-220
22. Mosmann T., Cherwinski H., Bond M., Giedlin M., and Coffman R. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 7 (1986) 2348-2357
23. Rengarajan J., Szabo S., and Glimcher L. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 10 (2000) 479-483
24. Strom T.B., Roy-Chaudhury P., Manfro R., Zheng X., Nickerson P., Wood K., et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8 5 (1996) 688-693
25. Warle M., Farhan A., Metselaar H., Hop W., Perrey C., Zondervan P., et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles?. Liver Transpl 9 2 (2003) 170-181
26. Lobashevsky A., Senkbeil R., Shoaf J., Mink C., Rowe C., Lobashevsky E., et al. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Clin Transplant 14 6 (2000) 533-542
27. Vaidya S., Cooper T.Y., and Avandsalehi J. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Transplantation 71 3 (2001) 422-428
28. Cavet J., Dickinson A., Norden J., Taylor P., Jackson G., and Middleton P. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 98 5 (2001) 1594-1600
29. Chen N., Gao Q., and Field E. Prevention of Th1 response is critical for tolerance. Transplantation 61 7 (1996) 1076-1083
30. Fitzpatrick D., and Kelso A. Independent regulation of cytokine genes in T cells: the paradox in the paradigm. Transplantation 65 1 (1998) 1-5
31. Fraser J., Straus D., and Weiss A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol Today 14 7 (1993) 357-362
32. Piccotti J., Chan S., VanBuskirk A., Eichwald E., and Bishop D. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?. Transplantation 63 6 (1997) 619-624
33. Coquet J.M., Chakravarti S., Kyparissoudis K., McNab F., Pitt L., McKenzie B., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci U S A 105 32 (2008) 11297-92
34. Moreno M., Molling J., von Mensdorff-Pouilly S., Verheijen R., Hooijberg E., Kramer D., et al. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses. J Immunol 181 4 (2008) 2446-2454
35. Lafaille M., and Lafaille J. CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 14 6 (2002) 771-778
36. Lobashevsky A., Senkbeil R., Shoaf J., Stephenson A., Skelton S., Burke R., et al. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Hum Immunol 63 5 (2002) 364-374
37. Dhiman N Ovsyannikova I., Vierkant R., Pankratz V., Jacobson R., and Poland G. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 272 (2008) 211-220
38. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P., and Hutchinson I. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 21 6 (1999) 1-3
39. Cartwright N., Demaine A., Hurlock N., McGonigle R., Rowe P., Shaw J., et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol 8 2 (2000) 109-114
40. Cartwright N., Keen L., Demaine A., Hurlock N., McGonigle R., Rowe P., et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol 8 4 (2001) 237-244
41. Beretta L., Cappiello F., Moore J., and Scorza R. Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: a further step ahead. Hum Immunol 69 3 (2008) 187-192
42. John R., Lietz K., Burke E., Ankersmit J., Mancini D., Suciu-Foca N., et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 100 19 Suppl (1999) 229-235
43. Lehrich R., Rocha P., Reinsmoen N., Greenberg A., Butterly D., Howell D., et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 66 4 (2005) 350-358
44. Seegers D., Zwiers A., Strober W., Pena A.S., and Bouma G. A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3 7 (2002) 419-423
45. Abbas A., Murphy K., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 6603 (1996) 787-793
46. Andrews R., Burrell L., Rosa-Rosa L., Cunningham C., Brzezinski J., Bernstein J., et al. Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. Clin Immunol 100 3 (2001) 298-304
47. Hershey G., Friedrich M., Esswein L., Thomas M., and Chatila T. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337 24 (1997) 1720-1725
48. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1 1 (1999) 3-19
49. Hackstein H., Kluter H., Fricke L., Hoyer J., and Bein G. The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival. Tissue Antigens 54 5 (1999) 471-477
50. Wilks A., and Oates A. The JAK/STAT pathway. Cancer Surv 27 (1996) 139-163
51. Mouzaki A., Theodoropoulou M., Gianakopoulos I., Vlaha V., Kyrtsonis M., and Maniatis A. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood 100 5 (2002) 1774-1779
52. Jiang S., Tsang J., and Lechler R. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance. Transplant Proc 38 10 (2006) 3199-3201
53. Dau P. Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis. J Neuroimmunol 62 2 (1995) 197-200
54. Dau P. Immunologic rebound. J Clin Apher 10 4 (1995) 210-217
55. Dau P. Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease. J Neuroimmunol 1990; 30(1); 15-21.